Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Forest to Acquire U.S. Marketing Rights to Saphris® (asenapine) from Merck
Forest to Acquire U.S. Marketing Rights to Saphris® (asenapine) from Merck
Forest to Acquire U.S. Marketing Rights to Saphris® (asenapine) from Merck
Submitted by
admin
on December 2, 2013 - 10:17am
Source:
Yahoo
News Tags:
Saphris
schizophrenia
Forest Labs
Merck
Headline:
Forest to Acquire U.S. Marketing Rights to Saphris® (asenapine) from Merck
Do Not Allow Advertisers to Use My Personal information
